Skip to content
Presentations
Presentations
2023 Global Presentations
Title
Type of presentation
Meeting
Country
City
Column 6
1
Artificial Intelligence in Cancer Research
Grandrounds
Tampa General Hospital Grandrounds
USA
Tampa
2/3/2023
2
3
There are no rows in this table
2022 Global Presentations
Title
Type of presentation
Meeting
Country
City
Date
1
AI in Hematologic Malignancies
Grandrounds
Atlantic Health Oncology
USA
Morristown, NJ
1/28/2022
2
The sate of ART in AI in health
Virtual
WEDI, Spotlight
USA
3/29/2022
3
AI-driven genomic precision diagnostics in hematologic malignancies
Virtual Webinar
The Clinical Genomics platform and Genomic Medicine, Lund University
Sweden
4/29/2022
4
AI in Hematologic Malignancies
Virtual
NEXT meeting
Spain
5/11/2022
5
State of AI in healthcare
Keynote
New Jersey Association of Osteopathic Physicians and Surgeons Annual meeting
USA
Atlantic City, NJ
4/27/2022
6
Current Artificial Intelligence Application in Oncology
Presenter
ASCO, Educational Session
USA
Chicago, Illinois
6/3/2022
7
The State of the Art of Artificial Intelligence in Healthcare
Keynote
In Vitro Biology Annual Meeting
USA
San Diego, California
6/7/2022
8
A Glimpse of the Future: AML and the Role of Artificial Intelligence
Virtual
4th Symposium on Controversies & Updates in Leukemia
Saudi Arabia
10/1/2022
9
Artificial Intelligence in Hematology: Current Challenges and Opportunities
Virtual
4th Symposium of Transplant and Cellular Therapy
Saudi Arabia
10
Artificial Intelligence in Cancer Research
Seminar Series
Incyte Pharma
USA
Wilmington, Delaware
10/5/2022
11
Challenges in the Application of Artificial Intelligence in Healthcare
Virtual
CureSearh Summit for Children’s Cancers
USA
9/15/2022
12
The State-of-the Art of AI in Cancer Care: Opportunity, Bias, Barriers and Gaps
Virtual
Sharing Progress in Cancer Care
Italy
10/24/2022
13
Artificial Intelligence in Risk Assessment and Prognosis
Virtual
Shaping the Future of Hematology
Germany
Leipzing
11/11/2022
14
The Primary MDS models is IPSSm, NO
Virtual
IACH
USA
2/23/2022
15
A Personalized Prediction Model in Myelodysplastic Syndromes
Presenter
International Working Group workshop on Myelodysplastic Syndromes
USA
Miami, Florida
6/24/2022
16
Artificial Intelligence in Myelodysplastic Syndromes
Presenter
International Working Group workshop on Myelodysplastic Syndromes
USA
Miami, Florida
6/24/2022
17
AI and Machine Learning: A New Frontier in Hematology
Chair
American Society of Hematology Annual meeting (68th)
USA
New Orleans, Louisiana
12/12/2022
18
AI 101: Why is AI and Machine Learning Important in Hematology?
Chair
American Society of Hematology Annual meeting (68th)
USA
New Orleans, Louisiana
12/12/2022
There are no rows in this table
Invited Presentations in Previous Years
Local/National
1. “Clofarabine, Idarubicin, and Cytarabine (CIA) as a Frontline Therapy for Patients with Newly Diagnosed Acute myeloid Leukemia: MD Anderson Cancer Center Research Retreat, Houston, USA, 6-2013
2. “A Novel Prognostic Model for Risk Stratification in Younger Patients with Intermediate Risk Acute Myeloid Leukemia, Society of Hematologic Oncology Meeting, Houston, USA, 9-2014
3. “Mutational Model to Predict Response to Hypomethylating Agents in Myelodysplastic Syndromes”, Society of Hematologic Oncology Meeting, Houston, USA, 9-2015
4. “Cracking the MDS Genome: Translating Genes into the Clinic”, Massachusetts General Hospital, Boston, MA, USA, 11-2015
5. “Cracking the MDS Genome: Translating Genes into the Clinic”, Cleveland Clinic Grand Rounds, Cleveland, USA, 12-2015
6. “Why Cancer Research Needs Artificial Intelligence”, Hematopoietic and Immune Cell Biology Disease Meeting, University Hospital, Ohio, USA, 4-2018
7. “Why Cancer Research Needs Artificial Intelligence”, Grand Rounds, Cleveland Clinic, USA, 10-2018
8. “Why Cancer Research Needs Artificial Intelligence”, Brainx Community Meeting, Cleveland, USA, 10-2018
9. “Artificial Intelligence the Cleveland Clinic Way”, Leukemia Program research mini retreat, Cleveland Clinic, Cleveland, USA, 10-2019
10. “Artificial Intelligence in Cancer Research: The CCCC Way”, Case Comprehensive Cancer Center mini-retreat, Cleveland, USA, 2-2019
11. “Harnessing the power of Artificial Intelligence in Cancer Research”, Flatiron Health, New York, USA, 3-2019
12. “Harnessing the power of Artificial Intelligence in Cancer Research”, Daiichi Sankyo, New Jersey, USA, 3-2019
13. Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, Enterprise Analytics Monthly meeting, Cleveland Clinic, Cleveland, USA, 8-2019
14. Harnessing the power of Artificial Intelligence in Myelodysplastic Syndromes”, Grand Rounds, Mount Saini Hospital, New York, USA, 6-2019
15. “Artificial Intelligence in Cancer Research: The CCCC Way”, Case Comprehensive Cancer Center Annual Research Retreat, Cleveland, USA, 7-2019
16. Artificial Intelligence in Healthcare: the Cleveland Clinic Way, C5Research Meeting, Department of Cardiology, Cleveland Clinic, USA, 7-2019
17. “Harnessing the power of Artificial Intelligence in Leukemia Research”, Mount Sinai Summer workshop in Clinical Research, New York, USA, 8-2019
18. “Artificial Intelligence in Medicine: the Cleveland Clinic Way”, Google Day at the Cleveland Clinic, Cleveland, USA, 8-2019
19. Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, Medical Operation Meeting, Cleveland Clinic, Cleveland, USA, 8-2019
20. Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, IT Department Monthly Meeting, Cleveland Clinic, Cleveland, USA, 8-2019
21. Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, Cancer Imaging Meeting, Case Comprehensive Cancer Center Seminars, Cleveland, USA, 9-2019
22. Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, Executive Director meeting, Heart and Vacular Institute, Cleveland Clinic, USA, 1-2020
23. An Artificial Intelligence Journey in Cancer Research", Case Comprehensive Cancer Center Seminar Series, 4/2020
24. “Data and Analytics for Risk Assessment”, Medical Intelligence Society Virtual Meeting, 7-2020
25. “AI In Hematology”, American Society of Hematology Executive Committee meeting, Santa Fe, New Mexico, 8-2021
26. “Leveraging the AI Legos at AWS to build Healthcare Solutions”, Healthcone day, Amazon Web Services 8-2021
27. “Machine Learning in Healthcare on AWS”, Seattle Children Urology Department Grand-Rounds, 8-2021.
28. “Machine Learning in Healthcare on AWS”, University of Miami, Department of Hematology and Medical Oncology Research meeting, 10-2021
29. “Machine Learning in Healthcare on AWS”, Ohio State University Bone marrow transplant Grand-round, 10-2021
30. “AI in Hematologic Malignancies”, Englander Institute of Precision Medicine, Cornel University Grand-rounds, 12-2021
31. “AI in Hematologic Malignancies”, Atlantic Health, Department of Hematology and Medical Oncology Grand-rounds, 12-2021
International
1. “A Novel Prognostic Model in Heavily Treated Patients with Myelodysplastic Syndromes, American Society of Hematology Annual Meeting, San Francisco, USA, 2014
2. “The Revised International Prognostic Scoring System Molecular, A validated and Dynamic Model in Treated Patients with Myelodysplastic Syndromes, American Society of Hematology Annual Meeting, Orlando, USA, 2015
3. Network-Based Analysis of Exome Sequencing Mutations Identified Molecular Subtypes of Myelodysplastic Syndromes, American Society of Hematology Annual Meeting, Orlando, USA, 2015
4. “Hansel and Gretel “Crumbs versus Clones”: Do Molecular Mutations Change Our Ability for Diagnosis, Prognosis and Selection of Treatment Options for MDS?, Satellite symposium,preceding the American Society of Hematology (ASH) 58th annual meeting, San Diego, CA, USA, 12-2016
5. “A proposal of a Model to Predict Acute Myeloid Leukemia Progression in MDS Using Machine Learning”, International Working Group for MDS Meeting, San Diego, CA, 12-2016
6. “Prediction models in Chronic Myelomonocytic Leukemia”, International Working Group for MDS/MPN, Valencia, Spain, 5-2017
7. “ Models Heterogeneity in Chronic Myelomonocytic Leukemia”, International Working Group for MDS/MPN, Atlanta, USA, 12-2017
8. “ Personalized Prediction Model to Risk Stratify Patients with Therapy-Related MDS”, International Working Group for MDS, Atlanta, USA, 2017
9. “Genomic Biomarkers to Predict Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes”, American Society of Hematology Annual Meeting, Atlanta, USA, 12-2017
10. “Why Cancer Research Needs Artificial Intelligence”, Webinar, Munich Leukemia Laboratory, Munich, Germany, 2018
11. “Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes”, American Society of Hematology Annual Meeting, Atlanta, USA, 12-2018
12. “A personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem cell Transplant in Patients with Myelodysplastic Syndromes”, American Society of Hematology Annual Meeting, San Diego, USA, 2018
13. “A personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes”, American Society of Hematology Annual Meeting, San Diego, USA, 2018
14. “The MDS Genomics-Prognosis Symbiosis”. Educational Presentation at The American Society of Hematology Annual Meeting, San Diego, USA, 2018
15. “Harnessing the power of Artificial Intelligence in Leukemia Research”, Toronto City Wide Grand Rounds, Toronto, Canada, 9-2019
16. “Machine Learning Based Algorithms”. International Academy for Clinical Hematology 2nd Annual Meeting, Paris, France, 9-2019
17. “Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, Khalifa University, Abu Dhabi, UAE, 10-2019
18. “Artificial Intelligence Education: Opportunities and Challenges”, Khalifa University, Abu Dhabi, UAE, 10-2019
19. “Artificial Intelligence in Healthcare: the Cleveland Clinic Way”, GITEX meeting, Dubai, UAE, 10-2019
20. “Future of Being (Healthcare), Panel discussion, GITEX meeting, Dubai, UAE, 10-2019
21. Emerging diagnostic tools and techniques, American Sociatey of Hematology Annual meeting, Session Moderator, 12-2019
22. “Treating MDS patients after Hypomethylating Agent Fialure”, Aplastic Anemia and MDS foundation Seminar Series, 6-2020
23. “Challenges In Diagnosis and Risk Stratificaiton of MDS, Eighth Annual Meeting of the Society of Hematologic Oncology Meeting, 9/12/2020
24. Advances in Myelodysplasia, Session Moderator, Acute Leukemia Forum, 10-2020
25. Predicting the Unpredictable: AI Practices for the Pandemic Landscape – And What’s Ahead, Panel Discussion, AI Champions Virtual Meeting, 8-2020
26. How Can I Rely on AI/ML Data Models?, Panel Discussion, Xavier AI Health Virtual Summit, 9-2020
27. Fireside Chat - The AI Enabled Future - Proactively Preventing Crisis through AI, Panel Discussion, Xavier AI Health Virtual Summit, 9-2020
28. “Artificial Intelligence in Diagnostic Hematology”. Scientific Workshop on Translational Molecular Diagnostics in Hematology, American Society of Hematology Annual Meeting, 12-2021
29. “AI and Machine Learning in Healthcare” Panel Discussion. Informatics Summit. Virtual, 11-2021
30. “State of Art in Artificial Intelligence in Health”. Global Digital Healthcare Summit, Virtual, 11- 2021
Keynote Speaker
1. Harnessing the power of Artificial Intelligence in Cancer Research, Keynote Speaker, Case Comprehensive Cancer research min-retreat, Cleveland, Ohio, USA, 2-2019
2. Artificial Intelligence in Healthcare: the Cleveland Clinic Way, Keynote Speaker, AI MED conference, California, 12-2019
3. Artificial intelligence and machine learning in precision medicine and how it relates to the pediatric gastroenterologist caring for the child with digestive disease. Plenary Session, Keynote
Speaker, North American Society for Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN)) annual meeting, 10-2020
4. “How Machine Learning can Contribute to Prognostic and Predictive Models. Plenary Session, 16th MDS International Meeting, Virtual, 9-2021
5. “State of Art in Artificial Intelligence in Health”. Global Summit - Telemedicine & Digital Health, Virtual, 11- 2021
Want to print your doc?
This is not the way.
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.